BusinessBioSig Technologies Adds Role of Chief Regulatory and Compliance Officer in Preparation for FDA SubmissionBy Nasdaq OMXNov 14, 2017, 1:00 PM UTC
BusinessCORRECTING and REPLACING -- Celsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian CancerBy Nasdaq OMXNov 14, 2017, 12:23 AM UTC
BusinessArbutus’ LNP Licensee Alnylam Receives Accelerated Assessment of Patisiran from European Medicines Agency (EMA)By Nasdaq OMXNov 13, 2017, 10:22 PM UTC
BusinessCelsion Files Immunotherapy Clinical Protocol for the Evaluation of GEN-1 to Treat Newly Diagnosed Ovarian CancerBy Nasdaq OMXNov 13, 2017, 10:15 PM UTC
BusinessInca Worldwide (OTC-Pink:QEDN) announces an alliance with the Colombian government to implement our program in ColombiaBy Nasdaq OMXNov 13, 2017, 2:01 PM UTC
BusinessFibrocell Reports Third Quarter 2017 Financial Results and Recent HighlightsBy Nasdaq OMXNov 13, 2017, 1:00 PM UTC
BusinessIP veteran Andrew Filler joins BioSig Technologies’ Board of DirectorsBy Nasdaq OMXNov 10, 2017, 1:00 PM UTC
BusinessMyriad Collaborates with Department of Veterans Affairs in Large Trial Evaluating the GeneSight® Test to Improve Mental Health Outcomes for VeteransBy Nasdaq OMXNov 10, 2017, 12:05 PM UTC
